TY  - JOUR
T1  - AUtologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus
AU  - Gitelman SE, Haller MJ, Schatz D
Y1  - 2009/08/12
N1  - 10.1001/jama.2009.1098
JO  - JAMA
SP  - 624
EP  - 625
VL  - 302
IS  - 6
N2  - 
From the safety perspective, we also wondered whether any infectious issues aside from pneumonia were noted. In particular, we would like to know if primary infection of cytomegalovirus or Epstein-Barr virus or reactivation occurred. Epstein-Barr virus reactivation was noted in a trial of treating new onset type 1 diabetes with an anti-CD3 monoclonal antibody (ChAglyCD3).2

SN  - 0098-7484
M3  - doi: 10.1001/jama.2009.1098
UR  - http://dx.doi.org/10.1001/jama.2009.1098
ER  -